Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLRMT | O00411 | 1/20 | 0.50 |
| ▸ | P2RX1 | P51575 | 3/20 | 0.41 |
| ▸ | P2RX3 | P56373 | 3/20 | 0.41 |
| ▸ | P2RX4 | Q99571 | 2/20 | 0.41 |
| ▸ | P2RX2 | Q9UBL9 | 1/20 | 0.38 |
| ▸ | ENTPD1 | P49961 | 2/20 | 0.37 |
| ▸ | P2RY2 | P41231 | 2/20 | 0.36 |
| ▸ | P2RY1 | P47900 | 2/20 | 0.36 |
| ▸ | P2RY11 | Q96G91 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4967938 | 0.91 | POLRMT (0.48) | POLRMTP2RX1P2RX3P2RX4P2RX2 | |
| SCHEMBL24074599 | 0.86 | POLRMT (0.49) | POLRMTP2RX1P2RX3P2RX4P2RX2 | |
| SCHEMBL10120887 | 0.85 | POLRMT (0.53) | POLRMTP2RX1P2RX3P2RX4P2RX2 | |
| SCHEMBL10143054 | 0.83 | POLRMT (0.49) | POLRMTP2RX1P2RX3P2RX4P2RX2 | |
| SCHEMBL22355496 | 0.83 | POLRMT (0.46) | POLRMTP2RX1P2RX3P2RX4P2RX2 | |
| SCHEMBL15998230 | 0.83 | POLRMT (0.50) | POLRMTP2RX1P2RX3P2RX4P2RX2 | |
| SCHEMBL4765352 | 0.83 | POLRMT (0.53) | POLRMTP2RX1P2RX3P2RX4P2RX2 | |
| SCHEMBL23047655 | 0.82 | POLRMT (0.49) | POLRMTP2RX1P2RX3P2RX4P2RX2 | |
| SCHEMBL24790489 | 0.80 | RIPK1 (0.33) | POLRMT | |
| SCHEMBL18666916 | 0.80 | POLRMT (0.32) | POLRMT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3785717-A1 | METHODS FOR TREATING CORONAVIRIDAE INFECTIONS | Gilead Sciences, Inc. (US) | 2021-03-03 | — | — | EP | disclosed |